Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah T Diepstraten

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Blood Reviews|January 9, 2019
Modelling human haemoglobin switchingSarah T Diepstraten, Adam H Hart
Biochemical Society Transactions|July 28, 2022
Last but not least: BFL-1 as an emerging target for anti-cancer therapiesGaoyuan Wang, Sarah T Diepstraten, Marco J Herold
Apoptosis : an International Journal on Programmed Cell Death|November 7, 2022
BCL-2 protein family: attractive targets for cancer therapyDeeksha Kaloni, Sarah T Diepstraten, Andreas Strasser, et al.
Developmental Cell|October 8, 2024
Don't fear the reaper: The role of regulated cell death in tumorigenesis and BH3-mimetics for cancer therapyJohn E La Marca, Gemma L Kelly, Andreas Strasser, et al.
Nature Reviews. Cancer|October 19, 2021
The manipulation of apoptosis for cancer therapy using BH3-mimetic drugsSarah T Diepstraten, Mary Ann Anderson, Peter E Czabotar, et al.
Oncogene|August 11, 2023
BCL-W makes only minor contributions to MYC-driven lymphoma developmentSarah T Diepstraten, John E La Marca, Catherine Chang, et al.
Cell Death and Differentiation|February 9, 2023
Lymphoma cells lacking pro-apoptotic BAX are highly resistant to BH3-mimetics targeting pro-survival MCL-1 but retain sensitivity to conventional DNA-damaging drugsSarah T Diepstraten, Savannah Young, John E La Marca, et al.
Development (Cambridge, England)|June 6, 2019
<i>Strip</i> and <i>Cka</i> negatively regulate JNK signalling during <i>Drosophila</i> spermatogenesisJohn E La Marca, Sarah T Diepstraten, Amy L Hodge, et al.
Cell Death and Differentiation|January 29, 2022
Loss of TRP53 reduces but does not overcome dependency of lymphoma cells on MCL-1Brandon J Aubrey, Margs S Brennan, Sarah T Diepstraten, et al.
Disease Models & Mechanisms|March 2, 2023
A Drosophila chemical screen reveals synergistic effect of MEK and DGKα inhibition in Ras-driven cancerJohn E La Marca, Robert W Ely, Sarah T Diepstraten, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Blood Reviews|January 9, 2019
Modelling human haemoglobin switchingSarah T Diepstraten, Adam H Hart
Biochemical Society Transactions|July 28, 2022
Last but not least: BFL-1 as an emerging target for anti-cancer therapiesGaoyuan Wang, Sarah T Diepstraten, Marco J Herold
Apoptosis : an International Journal on Programmed Cell Death|November 7, 2022
BCL-2 protein family: attractive targets for cancer therapyDeeksha Kaloni, Sarah T Diepstraten, Andreas Strasser, et al.
Developmental Cell|October 8, 2024
Don't fear the reaper: The role of regulated cell death in tumorigenesis and BH3-mimetics for cancer therapyJohn E La Marca, Gemma L Kelly, Andreas Strasser, et al.
Nature Reviews. Cancer|October 19, 2021
The manipulation of apoptosis for cancer therapy using BH3-mimetic drugsSarah T Diepstraten, Mary Ann Anderson, Peter E Czabotar, et al.
Oncogene|August 11, 2023
BCL-W makes only minor contributions to MYC-driven lymphoma developmentSarah T Diepstraten, John E La Marca, Catherine Chang, et al.
Cell Death and Differentiation|February 9, 2023
Lymphoma cells lacking pro-apoptotic BAX are highly resistant to BH3-mimetics targeting pro-survival MCL-1 but retain sensitivity to conventional DNA-damaging drugsSarah T Diepstraten, Savannah Young, John E La Marca, et al.
Development (Cambridge, England)|June 6, 2019
<i>Strip</i> and <i>Cka</i> negatively regulate JNK signalling during <i>Drosophila</i> spermatogenesisJohn E La Marca, Sarah T Diepstraten, Amy L Hodge, et al.
Cell Death and Differentiation|January 29, 2022
Loss of TRP53 reduces but does not overcome dependency of lymphoma cells on MCL-1Brandon J Aubrey, Margs S Brennan, Sarah T Diepstraten, et al.
Disease Models & Mechanisms|March 2, 2023
A Drosophila chemical screen reveals synergistic effect of MEK and DGKα inhibition in Ras-driven cancerJohn E La Marca, Robert W Ely, Sarah T Diepstraten, et al.
Pageof 3